Purchase Order 36C25226P0110
Award Date 12/15/25
Potential Completion Date 12/14/26
Potential Value $2M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Boca Raton, FL 33432, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Exelan Pharmaceuticals Inc., a Boca Raton, Florida-based pharmaceutical manufacturer and distributor, was awarded a $1 million firm fixed-price purchase order by the Department of Veterans Affairs Veterans Integrated Service Network 10 on December 15, 2025, for the supply of Lenalidomide/Revlimid doses. The contract carries an ultimate completion date of December 14, 2026, and will be performed at the company's facility in Boca Raton, Florida. No set-aside designation was applied to this...
- Exelan Pharmaceuticals Inc., a Boca Raton, Florida-based pharmaceutical manufacturer and distributor, was awarded a firm fixed-price purchase order valued at $2.0 million by Veterans Integrated Service Network 12 (VISN 12) on December 15, 2025, for the supply of Lenalidomide/Revlimid. The contract, which carries no set-aside designation and was awarded through open competitive procurement, will be performed at the awardee's Boca Raton facility with delivery to the VA facility in Danville,...
- The Department of Veterans Affairs, Veterans Integrated Service Network 12, awarded a $3 million firm fixed-price purchase order to Exelan Pharmaceuticals Inc. for the supply of generic lenalidomide. The contract, awarded on December 15, 2025, with an ultimate completion date of December 14, 2026, will be performed in Boca Raton, Florida. No set-aside designation was used in this competitive procurement, allowing Exelan to compete openly for the award. Lenalidomide is an immunomodulatory...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 21, awarded a $29,090.18 firm fixed-price delivery order to Exelan Pharmaceuticals Inc. for the supply of Lenalidomide 10mg and 20mg tablets. The contract, which carries an ultimate completion date of February 3, 2026, was awarded on December 3, 2025, with no set-aside designation. Performance will be executed at Exelan's facility in Boca Raton, Florida. This delivery order falls under the GSA Federal Supply Schedule...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 23, awarded a delivery order to Exelan Pharmaceuticals Inc. on December 1, 2025, for the supply of Lenalidomide Capsules. This firm fixed-price delivery order carries a ceiling value of $1.21M and is scheduled for completion by September 30, 2026. The award was made without set-aside designation under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), allowing Exelan to compete openly against other...
- On December 11, 2025, the Department of Veterans Affairs, Veterans Integrated Service Network 21, awarded a $39,663 firm fixed-price delivery order to Exelan Pharmaceuticals Inc. for emergency pharmaceutical supplies. The contract calls for the delivery of Lenalidomide 10mg tablets (21 count) and Lenalidomide 15mg bottles, with two orders each of the specified National Drug Codes (76282-0698-48 and 76282-0699-47). The work is to be performed in Boca Raton, Florida, with an ultimate completion...
- The Department of Veterans Affairs Veterans Integrated Service Network 21 awarded an emergency delivery order to Exelan Pharmaceuticals Inc. on August 27, 2025, for the procurement of Lenalidomide in 15mg and 2.5mg formulations. This firm fixed-price contract, valued at $10,397.48, was funded through fiscal year 2025 Defense and Overseas Contingency Operations (DEOB) appropriations and carries an ultimate completion date of September 30, 2025. The award was issued without a set-aside...
- Exelan Pharmaceuticals Inc., a pharmaceutical manufacturing and distribution company based in Boca Raton, Florida, was awarded a firm fixed-price delivery order by Veterans Integrated Service Network 20 (VISN 20) on November 3, 2025, for the supply of Lenalidomide. The contract ceiling value is $1.28M with an ultimate completion date of September 30, 2026. This delivery order was issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) with no set-aside designation,...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 7, awarded a delivery order valued at $4.77M to Exelan Pharmaceuticals Inc. for the supply of Lenalidomide Capsules. This firm fixed-price contract, awarded on December 8, 2025, with an ultimate completion date of December 7, 2026, was issued without a set-aside designation, allowing full and open competition. The contract is performed in Boca Raton, Florida, where Exelan maintains its pharmaceutical manufacturing and...
- This federal contract award is for the delivery of LENALIDOMIDE 15MG to the U.S. Department of Veterans Affairs (VA), which is a civilian agency. The contract was awarded to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $10,034.79 and an ultimate completion date of September 5, 2025. The contract is not set-aside and was awarded under Exelan's Federal Supply...